Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

An Open-label Long-term Safety Study of Buntanetap in Participants With AD

This study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD.

Participants needed: 400
Trial details
Phase: Phase 2, Phase 3Age: 55+Biological sex: AllType: InterventionalSponsor: Annovis Bio Inc.Updated: Aug 19, 2026
Eligibility criteria

Has participated in a prior Alzheimer's clinical trial with buntanetap. [+8]

Has history of psychiatric disorder such as schizophrenia, bipolar disorder, or... [+22]

Read more
Status: Recruiting

A Study of Buntanetap in Participants With PD

This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conducted with two cohorts. Cohort 1 will enroll via invitation only for PD participants who have previously participated in buntanetap clinical trials. Cohort 2 will be for PD participants who are receiving deep brain stimulation (DBS) treatment. Qualified participants will receive buntanetap 30mg QD after a screening period of up to 42 days.

Participants needed: 500
Trial details
Phase: Phase 2, Phase 3Age: 40-85Biological sex: AllType: InterventionalSponsor: Annovis Bio Inc.Updated: Jul 21, 2026Locations: 27
Eligibility criteria

Diagnosis of idiopathic PD according to MDS Clinical Diagnostic Criteria for Par... [+22]

Cohort 1 only: Is currently receiving DBS treatment. (Participant may enroll in... [+22]

Read more